超皮耳神经神经刺激对慢性便秘的影响:一个多中心,随机对照研究
Tangyi Liu1, Zeyu Wang1, Yunling Li2
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, China.
United European gastroenterology journal
|May 13, 2025
概括
通过皮肤进行耳膜神经刺激 (taVNS) 对成年人慢性便秘没有显著的益处. 这项为期4周的研究发现,taVNS和假药治疗之间的反应率相似,这表明疗效有限.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 医疗器械 医疗器械
背景情况:
- 慢性便秘影响了相当一部分成年人群,影响了他们的生活质量.
- 慢性便秘的当前治疗选择具有局限性和可变的疗效.
- 穿皮耳神经刺激 (taVNS) 是一种新兴的神经调节技术,具有潜在的治疗应用.
研究的目的:
- 评估通过皮肤进行耳耳神经刺激 (taVNS) 的疗效和安全性,作为诊断为慢性便秘的成年患者的治疗方法.
- 为了比较活跃taVNS与虚假手术在改善肠功能和相关症状方面的有效性.
主要方法:
- 采用随机对照试验设计,招募符合慢性便秘罗马IV标准的成年患者.
- 参与者被分配到活跃的taVNS或假taVNS,每天两次接受30分钟的会议,持续四周.
- 主要结局是应答率,定义为完全自发性排便和减少救援药物的使用;次要结局包括症状得分和不良事件.
主要成果:
- 该研究因在中间分析期间观察到的效率不足而提前终止.
- 四周后,taVNS组 (17%) 和假taVNS组 (19%) 的反应率相似,没有统计学上显著的差异.
- 没有报告任何严重不良事件,这表明taVNS在这个人群中具有有利的安全性.
结论:
- 四周的25赫兹taVNS在治疗成人慢性便秘方面没有表现出有效性.
- 根据研究的参数,这些发现不支持使用taVNS作为治疗这种疾病的干预措施.
- 可能需要进一步的研究来探索不同的taVNS参数或患者群体,但目前的证据不支持.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
117
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
117
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
143
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
143
Irritable Bowel Syndrome III: Medical and Nursing Management
123
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
123
Irritable Bowel Syndrome I: Introduction
209
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
209
Chronic Bowel Disorders: Introduction
336
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
336
Drugs Affecting GI Tract Motility: Other Laxatives
131
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
131


